Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Teva Pharmaceutical Industries Ltd. announces the approval of the generic equivalent to Lovaza® (omega-3-acid ethyl esters aapsules, USP), in the United States. "Teva believes it is first-to-file and thus far is the only company to receive an...

Mersana Therapeutics, a company specializing antibody drug conjugates (ADCs) and related technology, has entered into a collaboration agreement with Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company...

Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories Ltd  have entered into definitive agreements under which Sun Pharma will acquire 100% of Ranbaxy in an all-stock transaction for $3.2 billion. Under these agreements, Ranbaxy...

Sanofi and its subsidiary Genzyme report that following discussions with FDA,  the company plans to resubmit in the second quarter its supplemental biologics license application seeking approval of Lemtrada (alemtuzumab) for the treatment...

Impax Laboratories Inc. has appointed Jeffrey D. Nornhold as senior vice-president, technical operations and will oversee the company's manufacturing, supply chain, quality and technical operations. Nornhold previously served as the company's...

Baxter International Inc. has agreed to acquire all of the outstanding membership interests of Chatham Therapeutics for $70 million. As a result of the transaction, Baxter will acquire Chatham's developmental gene therapy programs directed toward...

Par Pharmaceutical Companies, Inc. has named Terrance J. Coughlin chief operating officer. In this capacity, Coughlin will be responsible for Par's global manufacturing activities, research and development efforts and will be instrumental in...